Volume 15 Issue 2
Peer Reviewed
The Four Trends Set to Disrupt Highly Regulated Industries in 2023 Individual Device Identification Coding and Marking for the New Dimension in Patient Health and Safety Why an Outcome-driven Approach to Supply Chain Is a Strategic Advantage for Pharmaceutical Businesses Advancements of Gene Editing Technologies (CRISPR/Cas9)
Sponsor Company:
www.international-pharma.com